Kyung Soo Lee Selected Research

Kyung Soo Lee Research Topics

Disease

39	Neoplasms (Cancer) 05/2022 - 06/2003
16	Adenocarcinoma of Lung 01/2019 - 05/2011
15	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2022 - 09/2005
11	Lung Diseases (Lung Disease) 01/2021 - 07/2005
10	Bronchiectasis 04/2023 - 04/2005
10	Neoplasm Metastasis (Metastasis) 06/2019 - 06/2003
8	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2023 - 10/2002
7	Lung Neoplasms (Lung Cancer) 12/2012 - 11/2004
5	Pneumonia (Pneumonitis) 01/2022 - 10/2018
5	Adenocarcinoma 01/2018 - 04/2012
4	Infections 02/2023 - 04/2005
4	Cysts 02/2014 - 07/2002
3	Esophageal Squamous Cell Carcinoma 01/2022 - 11/2004
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 10/2002
3	Polymyositis 01/2022 - 10/2002
3	Dermatomyositis (Dermatopolymyositis) 01/2022 - 10/2002
3	Rheumatoid Arthritis 01/2022 - 10/2002
3	Ankylosing Spondylitis 01/2022 - 10/2002
3	Mixed Connective Tissue Disease (MCTD) 01/2022 - 10/2002
3	Disease Progression 03/2021 - 02/2016
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2021 - 11/2011
3	Idiopathic Pulmonary Fibrosis 01/2021 - 10/2002
3	Solitary Pulmonary Nodule 08/2008 - 10/2004
2	Lung Injury 01/2024 - 06/2007
2	Fibrosis (Cirrhosis) 04/2023 - 10/2002
2	COVID-19 01/2023 - 01/2020
2	Sjogren's Syndrome (Sjogren Syndrome) 01/2022 - 01/2021
2	Connective Tissue Diseases (Connective Tissue Disease) 01/2022 - 01/2021
2	Diffuse Scleroderma (Progressive Systemic Sclerosis) 01/2021 - 10/2002
2	Vascular Diseases (Vascular Disease) 01/2020 - 10/2002
2	Breast Neoplasms (Breast Cancer) 01/2017 - 10/2015
2	Extensively Drug-Resistant Tuberculosis 11/2015 - 05/2009
2	Sarcoma (Soft Tissue Sarcoma) 02/2014 - 01/2004
2	Bronchiolitis 10/2013 - 04/2005
2	Hemorrhage 07/2012 - 10/2002
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2012 - 06/2003
2	Hamman-Rich Syndrome (Hamman Rich Syndrome) 11/2011 - 03/2006
2	Granuloma 09/2008 - 02/2007
2	Lymphatic Metastasis 05/2008 - 01/2008
2	Pulmonary Tuberculosis 04/2007 - 04/2004
2	Bronchiolo-Alveolar Adenocarcinoma (Adenocarcinoma, Bronchiolo Alveolar) 10/2005 - 11/2004
1	Malignant Pleural Effusion 09/2023
1	Pulmonary Edema 06/2023
1	Pulmonary Arterial Hypertension 06/2023
1	Post-Acute COVID-19 Syndrome 01/2023
1	Organizing Pneumonia 01/2023
1	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 01/2023
1	Pulmonary Hypertension 03/2022
1	Pulmonary Infarction 03/2022
1	Hypoxia (Hypoxemia) 03/2022
1	Systemic Scleroderma (Systemic Sclerosis) 01/2022
1	Pathologic Complete Response 01/2022
1	Human Influenza (Influenza) 01/2020
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 01/2019
1	Pulmonary Alveolar Proteinosis 10/2018
1	Rare Diseases (Rare Disease) 10/2018

Drug/Important Bio-Agent (IBA)

17	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 06/2019 - 06/2003
9	Anti-Bacterial Agents (Antibiotics)IBA 01/2019 - 10/2005
7	Biomarkers (Surrogate Marker)IBA 01/2018 - 07/2012
6	AcidsIBA 05/2009 - 04/2005
5	ErbB Receptors (EGF Receptor)IBA 01/2019 - 05/2011
5	Tyrosine Kinase InhibitorsIBA 11/2016 - 07/2011
3	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2021
3	Anaplastic Lymphoma KinaseIBA 06/2018 - 01/2015
3	Fluorine-18IBA 11/2007 - 11/2004
2	Messenger RNA (mRNA)IBA 01/2023 - 05/2008
2	Indicators and Reagents (Reagents)IBA 03/2022 - 10/2018
2	beta-cyclodextrin tetradecasulfate (CTDS)IBA 01/2022 - 01/2021
2	CollagenIBA 01/2020 - 10/2002
2	Contrast MediaIBA 01/2017 - 11/2005
2	IodineIBA 01/2016 - 11/2012
2	Rifampin (Rifampicin)FDA LinkGeneric 01/2015 - 02/2007
2	Ethambutol (Myambutol)FDA LinkGeneric 01/2015 - 02/2007
2	MucinsIBA 03/2013 - 10/2005
2	ferric oxide (iron oxide)IBA 12/2012 - 01/2006
1	XenonIBA 01/2024
1	VaccinesIBA 01/2023
1	AntigensIBA 01/2023
1	DNA (Deoxyribonucleic Acid)IBA 05/2022
1	4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA 03/2022
1	AminesIBA 03/2022
1	ProcalcitoninIBA 03/2021
1	xylometazoline (stas)IBA 12/2018
1	Surface-Active Agents (Surfactants)IBA 10/2018
1	Genetic Markers (Genetic Marker)IBA 06/2018
1	Colloids (Colloid)IBA 01/2018
1	betaglycan (TGFBR3)IBA 01/2018

Therapy/Procedure

29	Therapeutics 06/2023 - 04/2004
8	Traction 04/2023 - 09/2012
5	Lymph Node Excision (Lymph Node Dissection) 06/2019 - 06/2003
5	Drug Therapy (Chemotherapy) 08/2015 - 09/2010
3	Aftercare (After-Treatment) 10/2018 - 04/2012
3	Neoadjuvant Therapy 01/2014 - 02/2011
2	Precision Medicine 01/2018 - 07/2012
2	Chemoradiotherapy 01/2015 - 08/2006
2	Thoracotomy 05/2013 - 07/2012
2	Esophagectomy 11/2004 - 06/2003
1	Catheters 09/2023
1	Immunotherapy 03/2019
1	Adjuvant Chemotherapy 06/2018